Try our Advanced Search for more refined results
New Jersey
-
February 19, 2026
Doc Fight Delays Trial In $22M McCarter & English Loan Suit
The delayed disclosure of thousands of documents has created "a lot of prejudice" against McCarter & English as it fights a $22.5 million professional malpractice lawsuit, and the impending trial must be pushed back again, a Connecticut state judge said Thursday.
-
February 19, 2026
Disqualification Bids Mount For Trio Leading NJ US Atty Office
A New Jersey criminal defendant who previously challenged the legality of former interim U.S. Attorney Alina Habba's appointment has now moved to disqualify the three assistant U.S. attorneys overseeing the office, aligning himself with a growing bloc of defendants saying the leadership structure violates federal appointment laws.
-
February 19, 2026
FedEx Reaches $8.5M Deal To Settle Warehouse Wage Suit
FedEx and workers at 17 of its New Jersey warehouses reached an $8.5 million deal to settle the workers' claims they weren't paid for the time spent going through security screenings and walking to time clocks before and after their shifts.
-
February 19, 2026
Woman Asks Justices For Relief From Tax Preparer's Fraud
A woman facing more than $300,000 in tax bills because her return preparer committed fraud on her filings decades ago asked the U.S. Supreme Court to overturn the Third Circuit's finding that she is responsible, saying it unfairly allows the IRS to bypass the statute of limitations.
-
February 18, 2026
DOJ Acknowledges Violations Of Court Orders For Immigrants
A senior U.S. Department of Justice official acknowledged that the government has violated dozens of court orders involving immigrants since early last December, according to a New Jersey federal judge's order directing government officials to detail how the Trump administration will ensure compliance with orders in the judicial district.
-
February 18, 2026
Hudson Tunnel Agency Blasts 'Threadbare' Union-Limits Suit
The Gateway Development Commission has urged a New Jersey federal judge to dismiss nearly all claims brought by a Garden State construction company over the use of a project labor agreement on a major segment of the Hudson Tunnel Project, arguing the suit rests on "conclusory and threadbare allegations."
-
February 18, 2026
Axsome Blocks Sleep Disorder Drug Generic Until 2040
Biopharmaceutical business Axsome Therapeutics Inc. has inked a deal to end lawsuits against Alkem Laboratories Ltd. over its generic version of a multimillion-dollar drug meant to help people with excessive daytime sleepiness, keeping the generic off the market for years.
-
February 18, 2026
McCarter & English Seeks Delay, Toss Of $22M Ethics Case
McCarter & English LLP doubled down on its bid to sink a $22.3 million professional negligence lawsuit by two insurance companies, arguing document production delays warrant nonsuit and that the court should, at the very least, push back a March trial date approaching in the case.
-
February 18, 2026
Will Jurors Penalize AI? Study Examines Trade Secrets Impact
A forthcoming academic study suggests juries may treat AI-enabled actions more harshly than human conduct in trade secrets disputes, resulting in what the authors call an “AI penalty.” Attorneys say reality is more complicated.
-
February 18, 2026
Feds Release $130M NY, NJ Gateway Hudson Tunnel Funds
New York and New Jersey officials said Wednesday that construction on the $16 billion rehabilitation of aging commuter train tunnels under the Hudson River would resume next week after the federal government released $130 million in funds that a federal judge in Manhattan recently ruled had been unlawfully frozen.
-
February 18, 2026
Neutrogena Paying $4.7M To Settle BIPA Suit Over App
A former Johnson & Johnson subsidiary has agreed to pay $4.7 million to settle a potential class action claiming it unlawfully stored and collected facial scans of people who used its Neutrogena Skin360 tool, according to a filing in New Jersey federal court.
-
February 18, 2026
Levi & Korsinsky To Lead Novo Nordisk Investor Class Action
Levi & Korsinsky LLP has been appointed lead counsel in a proposed securities class action accusing Novo Nordisk A/S of misleading investors about its 2025 revenue outlook, after a New Jersey federal judge approved the firm's selection by the investor with the largest financial stake in the case.
-
February 18, 2026
No Jurisdiction In Judicial Privacy Law Suits, NJ Court Told
Five data companies said Wednesday that a New Jersey federal court should toss suits alleging they violated the Garden State's judicial privacy law, arguing that they have no presence in the state and do not have enough contacts with it.
-
February 18, 2026
States, Unions Urge DC Circ. To Block Haiti TPS Termination
California-led states and a coalition of unions urged the D.C. Circuit to deny the Trump administration's push to end temporary protected status for Haiti during an ongoing legal challenge, arguing it would harm families, communities and the economy.
-
February 17, 2026
FTC, States Urged To Halt Meta's Plan For Face ID In Glasses
A consumer advocacy group is pushing the Federal Trade Commission and nearly a dozen state enforcers to shut down Meta's reported plans to add facial recognition capabilities to its smart glasses, arguing that the feature would pose "a grave risk to privacy, safety and civil liberties."
-
February 17, 2026
Camden Diocese Will Pay $180M More To Abuse Survivors
The Roman Catholic Diocese of Camden, New Jersey, and its insurers on Tuesday agreed to pay another $180 million into a trust for the benefit of survivors of clergy sexual abuse, reaching a deal with a tort claimant committee representing more than 300 survivors.
-
February 17, 2026
Atty Can't Both Lead And Rep Class In Lawsuit, NJ Court Says
An attorney can't be both the lead plaintiff and class counsel in a class action, a New Jersey appeals court ruled Tuesday, leaning on a more than 40-year-old state supreme court decision in denying class certification in a lawsuit accusing an electric bike maker of selling defective products.
-
February 17, 2026
Judge Rips Drugmakers' Borderline 'Disingenuous' Appeal Bid
A Connecticut federal judge has rejected generic-drug makers' request for a quick appeal of his ruling denying them summary judgment on states' claims they engaged in an "overarching conspiracy" to fix prices, slamming the request for being borderline "disingenuous," mischaracterizing his reasoning and ignoring direct evidence of alleged wrongdoing.
-
February 17, 2026
Multi-Color Noteholders Sue Barclays In Ch. 11 Collateral Fight
Unsecured noteholders for bankrupt label-maker Multi-Color Corp. are suing Barclays Bank PLC as Multi-Color's collateral agent, seeking a declaration that the bank holds liens only on some assets and not "substantially all" assets and property as stated previously in the Chapter 11 case.
-
February 17, 2026
3rd Circ. Tosses Appeal In Pa. City Bankruptcy Utility Dispute
The Third Circuit on Tuesday upheld a bankruptcy court's order prohibiting the Chester Water Authority from probing the bankrupt Pennsylvania city's attempts to dissolve the water authority and use its assets in Chapter 9.
-
February 17, 2026
States Say FEMA Ignoring Disaster Mitigation Funding Order
Two months after a federal judge ruled that the Trump administration's cancellation of a federal disaster mitigation program was illegal, the government has not shown any signs of restoring it, a coalition of states said Tuesday.
-
February 17, 2026
J&J Fights Beasley Allen's Bid To Pause Talc DQ Ruling
A New Jersey state court lacks standing to block an appellate panel's removal of Beasley Allen from representing hundreds of women with ovarian cancer pursuing claims against Johnson & Johnson over talcum powder, the pharmaceutical company has argued in an opposition brief.
-
February 17, 2026
Ex-McCarter & English Atty Adds Port Authority To Bias Case
A former McCarter & English LLP attorney suing the firm for alleged anti-veteran discrimination added the Port Authority of New York and New Jersey and the agency's head to the litigation this week, claiming they retaliated against him by canceling a charity event he runs.
-
February 17, 2026
Bayer AG Unveils $7.3B Deal For Roundup Users
Bayer AG unit Monsanto has agreed to pay up to $7.25 billion over as many as 21 years to resolve current and future claims that exposure to the weed killer Roundup caused non‑Hodgkin lymphoma, under a proposed nationwide class settlement filed Tuesday in Missouri state court in St. Louis.
-
February 17, 2026
AG Ends Pursuit Of RICO Case Against NJ Power Broker
The New Jersey Attorney General's Office said Tuesday that it will not take its criminal racketeering case against South Jersey power broker George E. Norcross III to the state high court, effectively ending its prosecution of him and his associates.
Expert Analysis
-
And Now A Word From The Panel: Choosing MDL Venues
One of the most interesting yet least predictable facets of the Judicial Panel on Multidistrict Litigation's practice is venue — namely where the panel decides to place a new MDL proceeding — and its choices reflect the tension between neutrality and case-specific factors, says Alan Rothman at Sidley.
-
8 Steps For Industrial Property Buyers To Limit Enviro Liability
Ongoing litigation over the U.S. Environmental Protection Agency’s designation of PFAS as hazardous site contaminants demonstrates the liabilities that industrial property purchasers risk inheriting, but steps to guarantee rigorous environmental compliance, anticipate regulatory change and allocate cleanup responsibilities can mitigate this uncertainty, say attorneys at ArentFox Schiff.
-
Series
Law School's Missed Lessons: Mastering Time Management
Law students typically have weeks or months to prepare for any given deadline, but the unpredictability of practicing in the real world means that lawyers must become time-management pros, ready to adapt to scheduling conflicts and unexpected assignments at any given moment, says David Thomas at Honigman.
-
Courts Keep Upping Standing Ante In ERISA Healthcare Suits
As Article III standing becomes increasingly important in litigation brought by employer-sponsored health plan members under the Employee Retirement Income Security Act, several recent cases suggest that courts are taking a more scrutinizing approach to the standing inquiry in both class actions and individual matters, say attorneys at Crowell & Moring.
-
How Hyperlinks Are Changing E-Discovery Responsibilities
A recent e-discovery dispute over hyperlinked data in Hubbard v. Crow shows how courts have increasingly broadened the definition of control to account for cloud-based evidence, and why organizations must rethink preservation practices to avoid spoliation risks, says Bree Murphy at Exterro.
-
More NJ Case Law On LLCs Would Aid Attys, Litigants, Biz
More New Jersey court opinions would facilitate the understanding of the nuances of the state's Revised Uniform Limited Liability Company Act, including on breach of the duty of loyalty, oppression, piercing the corporate veil and derivative actions, says Gianfranco Pietrafesa at Archer & Greiner.
-
State False Claims Acts Can Help Curb Opioid Fund Fraud
State versions of the federal False Claims Act can play an important role in policing the misuse of opioid settlement funds, taking a cue from the U.S. Department of Justice’s handling of federal fraud cases involving pandemic relief funds, says Kenneth Levine at Stone & Magnanini.
-
Series
Writing Musicals Makes Me A Better Lawyer
My experiences with writing musicals and practicing law have shown that the building blocks for both endeavors are one and the same, because drama is necessary for the law to exist, says Addison O’Donnell at LOIS Law.
-
Diverging FAA Preemption Rulings Underscore Role Of Venue
Two recent rulings evaluating Federal Arbitration Act preemption of state laws — one from the California Supreme Court, upholding the state law, and another from a New York federal court, upholding the arbitration agreement — demonstrate why venue should be a key consideration when seeking to enforce arbitration clauses, say attorneys at Hollingsworth.
-
Series
Adapting To Private Practice: From Va. AUSA To Mid-Law
Returning to the firm where I began my career after seven years as an assistant U.S. attorney in Virginia has been complex, nuanced and rewarding, and I’ve learned that the pursuit of justice remains the constant, even as the mindset and client change, says Kristin Johnson at Woods Rogers.
-
Rebutting Price Impact In Securities Class Actions
Defendants litigating securities cases historically faced long odds in defeating class certification, but that paradigm has recently begun to shift, with recent cases ushering in a more searching analysis of price impact and changing the evidence courts can consider at the class certification stage, say attorneys at Katten.
-
7 Document Review Concepts New Attorneys Need To Know
For new associates joining firms this fall, stepping into the world of e-discovery can feel like learning a new language, but understanding a handful of fundamentals — from coding layouts to metadata — can help attorneys become fluent in document review, says Ann Motl at Bowman and Brooke.
-
Agentic AI Puts A New Twist On Attorney Ethics Obligations
As lawyers increasingly use autonomous artificial intelligence agents, disciplinary authorities must decide whether attorney responsibility for an AI-caused legal ethics violation is personal or supervisory, and firms must enact strong policies regarding agentic AI use and supervision, says Grace Wynn at HWG.
-
Series
Being A Professional Wrestler Makes Me A Better Lawyer
Pursuing my childhood dream of being a professional wrestler has taught me important legal career lessons about communication, adaptability, oral advocacy and professionalism, says Christopher Freiberg at Midwest Disability.
-
Patent Claim Lessons From Fed. Circ.'s Teva Decision
The Federal Circuit's recent decision in Janssen v. Teva is an important precedent for parties drafting patent claims or litigating obviousness where the prior art has potentially overlapping ranges for a claimed element, and may be particularly instructive to patent applicants in the pharmaceutical field, say attorneys at Cooley.